Form 4: Syros Pharmaceuticals' Chief Medical Officer Reports Stock Transactions
SEC Form 4 Filing
Chief Medical Officer David Roth reports stock transactions related to restricted stock units of Syros Pharmaceuticals.
Summary
- On October 31, 2024, David Roth, the Chief Medical Officer of Syros Pharmaceuticals, reported transactions involving the company's common stock.
- Roth acquired 18,875 shares of common stock upon the vesting of restricted stock units.
- Simultaneously, 6,776 shares were disposed of to cover tax withholding obligations at a price of $2.09 per share.
- Following these transactions, Roth directly owns 12,099 shares of Syros Pharmaceuticals' common stock.
- The restricted stock units were granted on October 6, 2022, and vested in two equal installments on October 31, 2023, and October 31, 2024.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities and beneficial ownership of company stock.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 10/06/2022 | Date of restricted stock unit award grant. |
| 10/31/2023 | First vesting date of restricted stock units (50%). |
| 10/31/2024 | Date of stock transactions (vesting and tax withholding) and second vesting date of restricted stock units (50%). |
| 11/04/2024 | Date of signature on the Form 4 filing. |
Keywords
Syros Pharmaceuticals, David Roth, Chief Medical Officer, Stock Transactions, Restricted Stock Units, Form 4, Vesting, Tax Withholding, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.